NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness (NCT04471909) | Clinical Trial Compass
RecruitingNot Applicable
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
United States110 participantsStarted 2020-10-20
Plain-language summary
Prospective, non-randomized, multi-center clinical investigation of the NEXUSâ„¢ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Male and female age ≥ 18.
✓. Proximal/ascending native or previously implanted surgical graft landing zone of appropriate length
✓. Proximal/ascending native or previously implanted surgical graft landing zone of appropriate diameter
✓. Distal/descending native landing zone of appropriate length
✓. Distal/descending native landing zone of appropriate diameter
✓. Brachiocephalic trunk native landing zone of appropriate length
✓. Brachiocephalic trunk native landing zone of appropriate diameter
✓. Appropriate take off angle between the Brachiocephalic Artery and the Aortic Arch perpendicular
Exclusion criteria
✕. Acute dissection
✕. Lesions that can be safely treated with TEVAR landing in zone 2 (with or w/o LSA vascularization)